RenovoRx, Inc.
RNXT· Nasdaq
Released May 10, 2024, after the close
10-Q filed May 10, 2024, 40 days after period end · 0001493152-24-018704
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$1.08M | -$3.26M | -$3.00M | -$1.15M |
| EPS Diluted | -$0.07 | -$0.36 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
RenovoRx, Inc. · CIK 1574094 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2024 · filed May 10, 2024 · 40 d after period end
+0.7% from the close of May 10, 2024 to the close of May 14, 2024, the first after the release.